Kevin M. Maloney

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Georgia State University

MedicineImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model”.

Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa552

N/A

0DataRank · unranked

36 citations

Adrien Le Guillou, Robert A. Driggers, Supriya Sarkar, Emeli J. Anderson, Amyn A. Malik +2 more

A behavioral cascade of HIV seroadaptation among US men who have sex with men in the era of PrEP and U=U

medRxiv(2020)10.1101/2020.11.25.20238758

N/A

0DataRank · unranked

2 citations

Kevin M. Maloney, Travis Sanchez, Martina Morris, Patrick Janulis, Samuel M. Jenness +1 more